[go: up one dir, main page]

MD4232B1 - Medicament based on troxerutin and carbazochrome for the treatment of progressive hepatic cirrhosis associated with heart failure - Google Patents

Medicament based on troxerutin and carbazochrome for the treatment of progressive hepatic cirrhosis associated with heart failure Download PDF

Info

Publication number
MD4232B1
MD4232B1 MDA20120103A MD20120103A MD4232B1 MD 4232 B1 MD4232 B1 MD 4232B1 MD A20120103 A MDA20120103 A MD A20120103A MD 20120103 A MD20120103 A MD 20120103A MD 4232 B1 MD4232 B1 MD 4232B1
Authority
MD
Moldova
Prior art keywords
treatment
heart failure
carbazochrome
troxerutin
hepatic cirrhosis
Prior art date
Application number
MDA20120103A
Other languages
Moldavian (mo)
Romanian (ro)
Other versions
MD4232C1 (en
Inventor
Gheorghe Anghelici
Oleg Crudu
Ulviyya Mammadova
Original Assignee
Gheorghe Anghelici
Oleg Crudu
Ulviyya Mammadova
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gheorghe Anghelici, Oleg Crudu, Ulviyya Mammadova filed Critical Gheorghe Anghelici
Priority to MDA20120103A priority Critical patent/MD4232C1/en
Publication of MD4232B1 publication Critical patent/MD4232B1/en
Publication of MD4232C1 publication Critical patent/MD4232C1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to medicine, particularly to hepatology and can be used for the treatment of progressive hepatic cirrhosis associated with heart failure.Summary of the invention consists in that a medicament is used on the basis of troxerutin and carbazochrome, in a dose of 150 mg and, respectively, 1.5 mg, for the treatment of progressive hepatic cirrhosis associated with heart failure. At the same time, the medicament is administered 1 tablet, 2…3 times daily, per os, during 14…30 days.
MDA20120103A 2012-11-08 2012-11-08 Medicament based on troxerutin and carbazochrome for the treatment of progressive hepatic cirrhosis associated with heart failure MD4232C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20120103A MD4232C1 (en) 2012-11-08 2012-11-08 Medicament based on troxerutin and carbazochrome for the treatment of progressive hepatic cirrhosis associated with heart failure

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20120103A MD4232C1 (en) 2012-11-08 2012-11-08 Medicament based on troxerutin and carbazochrome for the treatment of progressive hepatic cirrhosis associated with heart failure

Publications (2)

Publication Number Publication Date
MD4232B1 true MD4232B1 (en) 2013-06-30
MD4232C1 MD4232C1 (en) 2014-01-31

Family

ID=48749683

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20120103A MD4232C1 (en) 2012-11-08 2012-11-08 Medicament based on troxerutin and carbazochrome for the treatment of progressive hepatic cirrhosis associated with heart failure

Country Status (1)

Country Link
MD (1) MD4232C1 (en)

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU581885B2 (en) * 1984-03-01 1989-03-09 Lamorna Investments Proprietary Limited Treatment of high protein oedemas by direct application of benzo-pyrones
CH671021A5 (en) * 1987-05-07 1989-07-31 Espanola Prod Quimicos Prodn. of hydroxy:ethylated diosmin mixts. - useful for treating intoxication
FR2661610B1 (en) * 1990-05-02 1994-09-30 Rhone Poulenc Sante NOVEL LYOPHILIZED FORM OF DIOSMINE AND ITS PREPARATION.
FR2661830B1 (en) * 1990-05-11 1992-09-04 Corbiere Jerome NOVEL PHARMACEUTICAL COMPOSITIONS BASED ON FLAVONOSIDE.
FR2668705A1 (en) * 1990-11-06 1992-05-07 Bouchara Sa Novel skin preparations having a phlebotonic action and process for preparing them
FR2692145B1 (en) * 1992-06-10 1995-05-05 Bellon Labor Sa Roger New composition for topical use containing diosmin.
FR2726469B1 (en) * 1994-11-08 1996-12-13 Adir PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION OF FLAVONOIDS
JPH08301757A (en) * 1995-05-10 1996-11-19 Kureha Chem Ind Co Ltd Hsp47 synthesis suppressing agent
BE1011151A3 (en) * 1997-05-13 1999-05-04 Jose Remacle Use of a pharmaceutical composition for treating and / or preventing ischemia.
FR2778663B1 (en) * 1998-05-15 2001-05-18 Coletica NOVEL ESTERS OF FLAVONOIDS, THEIR USE IN COSMETICS, DERMOPHARMACY, PHARMACY AND AGRI-FOOD
JP2000023635A (en) * 1998-07-10 2000-01-25 M P G Kk Granule nutrient auxiliary food
KR100291141B1 (en) * 1998-09-15 2001-07-12 박호군 Composition for preventing and treating atherosclerosis and hyperlipidemia, comprising diosmin
KR20000019717A (en) * 1998-09-15 2000-04-15 박호군 Composition comprising rutin and quercetin for preventing and treating hyperlipidemia, arteriosclerosis and liver disease
AU2001297027B2 (en) * 2000-09-11 2005-08-18 Stander, Michael D. Use of buchu extracts for hypertension
KR100291145B1 (en) * 2000-10-06 2001-05-15 박호군 Composition for preventing and treating atherosclerosis, hyperlipidemia, hepatic diseases and glycosemia, comprising neohesperidin dihydrochalcone
KR100291144B1 (en) * 2000-10-06 2001-05-15 박호군 Composition for preventing and treating atherosclerosis and hyperlipidemia, comprising diosmin
FR2845597B1 (en) * 2002-10-11 2005-03-11 Innothera Lab Sa DRY ORAL FORMULATION CONTAINING DIOSMINE AS A PHARMACEUTICAL FORM OF A TABLET TO BE CROQUERED
US20040132816A1 (en) * 2003-01-06 2004-07-08 Liao Medical Corporation Lipid metabolism and fructus crataegus
FR2857665B1 (en) * 2003-07-16 2006-02-10 Centre Nat Rech Scient NOVEL FLAVON DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
ITMI20050517A1 (en) * 2005-03-30 2006-09-30 Therapicon Srl PHARMACEUTICAL COMPOSITION OF A TYPICAL MICROCRYSTALLINE FRACTION OF FLAVONOIDS
CN100444847C (en) * 2006-01-11 2008-12-24 刘展欣 Micronize diosmin and hesperidine composition suppository
MX2007011002A (en) * 2007-09-07 2009-03-09 World Trade Imp Export Wtie Ag Pharmaceutical composition combining various venotonic and vasoprotective agents for the treatment of chronic venous insufficiency.
MD3987C2 (en) * 2009-09-03 2010-07-31 Георге АНГЕЛИЧ Use of Diosmine for the treatment of advancing hepatic cirrhosis associated with cardiac insufficiency

Also Published As

Publication number Publication date
MD4232C1 (en) 2014-01-31

Similar Documents

Publication Publication Date Title
MY159353A (en) Pirfenidone treatment for patients with atypical liver function
UA105191C2 (en) Treatment with pirfenidone of patients with abnormal liver function
PE20142319A1 (en) MULTIPLE SCLEROSIS TREATMENT WITH A COMBINATION OF LAQUINIMOD AND GLATIRAMER ACETATE
HK1221646A1 (en) Use of high dose pridopidine for treating huntington's disease
JP2013155188A5 (en)
CL2014002935A1 (en) Method to treat a human patient with multiple sclerosis with laquinimod, at a daily dose of about 1.2mg; an oral unit dosage form of 1.2 mg of laquinimod and a carrier
MX2016011333A (en) Drug delivery systems and methods for treatment of bladder cancer with gemcitabine.
MX374612B (en) Regulation of glucose metabolism using anti-cgrp antibodies
NZ700924A (en) Dosage regimen for a pi-3 kinase inhibitor
MX2016008027A (en) Use of laquinimod to delay huntington's disease progression.
MD4232B1 (en) Medicament based on troxerutin and carbazochrome for the treatment of progressive hepatic cirrhosis associated with heart failure
MD4231B1 (en) Medicament based on troxerutin and carbazochrome for the treatment of portal gastropathies in hepatic cirrhosis
MD3987C2 (en) Use of Diosmine for the treatment of advancing hepatic cirrhosis associated with cardiac insufficiency
MD4458B1 (en) Use of Polybiolin drug in patients with liver cirrhosis
MD3986C2 (en) Use of Diosmine for the treatment of portal gastropathies in the hepatic cirrhosis
NZ600486A (en) Pirfenidone treatment for patients with atypical liver function
Schmalbach Citrates/rituximab
UA111312C2 (en) Treatment of acute coronary syndrome without st-segment elevation in patients with ischemic heart disease and metabolic syndrome following transcutaneous transluminar coronary angioplasty
Gola Various toxicities: 12 case reports
Kang Encephalopathy: 2 case reports
UA103788U (en) Method for treatment of acute coronary syndrome without st-segment elevation in patients with ischemic heart disease and metabolic syndrome following percutaneous transluminar coronary angioplasty
UA106056U (en) METHOD OF TREATMENT OF PATIENTS WITH PATIENTS WITH COMBINED METABOLIC SYNDROME AND INCREASED LEVEL OF INDICATORS OF SYSTEMIC INFLAMMATION
UA101141U (en) The method of correction of the dyslipidemia in patients with myocardial infarction in combination with nonalcoholic steatohepatitis
UA105586U (en) Method for treating hepatic encephalopathy
UA89638U (en) Method for treating aged patients with syndrome of vascular cognitive impairment

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)